cilomilast has been researched along with berotek in 2 studies
| Studies (cilomilast) | Trials (cilomilast) | Recent Studies (post-2010) (cilomilast) | Studies (berotek) | Trials (berotek) | Recent Studies (post-2010) (berotek) |
|---|---|---|---|---|---|
| 162 | 13 | 42 | 1,786 | 520 | 111 |
| Protein | Taxonomy | cilomilast (IC50) | berotek (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.06 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Advenier, C; Devillier, P; Fagon, JY; Faisy, C; Guerot, E; Naline, E; Risse, PA | 1 |
2 other study(ies) available for cilomilast and berotek
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Bronchi; Bronchial Hyperreactivity; Carboxylic Acids; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Endothelin-1; Fenoterol; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Nitriles; Phosphodiesterase Inhibitors; Rolipram | 2006 |